Invacare Retained Earnings (Accumulated Deficit) 2010-2023 | IVCRQ

Invacare retained earnings (accumulated deficit) from 2010 to 2023. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Invacare Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2022 $-78
2021 $23
2020 $59
2019 $87
2018 $142
2017 $188
2016 $266
2015 $311
2014 $338
2013 $396
2012 $365
2011 $364
2010 $370
2009 $346
Invacare Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023-03-31 $-120
2022-12-31 $-78
2022-09-30 $-58
2022-06-30 $-23
2022-03-31 $-2
2021-12-31 $23
2021-09-30 $21
2021-06-30 $43
2021-03-31 $54
2020-12-31 $59
2020-09-30 $64
2020-06-30 $71
2020-03-31 $88
2019-12-31 $87
2019-09-30 $107
2019-06-30 $115
2019-03-31 $128
2018-12-31 $142
2018-09-30 $144
2018-06-30 $157
2018-03-31 $173
2017-12-31 $188
2017-09-30 $206
2017-06-30 $225
2017-03-31 $249
2016-12-31 $266
2016-09-30 $284
2016-06-30 $290
2016-03-31 $302
2015-12-31 $311
2015-09-30 $314
2015-06-30 $322
2015-03-31 $331
2014-12-31 $338
2014-09-30 $348
2014-06-30 $364
2014-03-31 $378
2013-12-31 $396
2013-09-30 $402
2013-06-30 $386
2013-03-31 $399
2012-12-31 $365
2012-09-30 $372
2012-06-30 $370
2012-03-31 $372
2011-12-31 $364
2011-09-30 $400
2011-06-30 $387
2011-03-31 $377
2010-12-31 $370
2010-09-30 $363
2010-06-30 $348
2010-03-31 $349
2009-12-31 $346
2009-09-30 $329
2009-06-30 $316
2009-03-31 $309
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47